This kit is used for genotyping human CYP2C9 gene c.1075 and VKORC1 gene -1639 from genomic DNA extracted from patients' peripheral blood. Variations in two genes CYP2C9 and VKORC1 contribute significantly to the variability among patients in dose requirements for warfarin. The test results can provide guidance for personalized clinical treatment.
Product Advantages
1、Recommended by the clinical guidelines
2、High accuracy: having a unique internal reference design
3、Easy to use and fast turn-around
2、High accuracy: having a unique internal reference design
3、Easy to use and fast turn-around
Target group
1、Patients with atrial fibrillation
2、Patients with valve replacement
3、Patients with deep vein thrombosis
4、Patients with pulmonary embolism, etc.
2、Patients with valve replacement
3、Patients with deep vein thrombosis
4、Patients with pulmonary embolism, etc.
